Wei Zhang, Hong Liu, Wei-Liang Zhuang, Yuan Li, Li-Ping Xie, & You-Jia Hu. (2023). A Potential Antibody-Drug Conjugate Targeting Human LIV1 for the Treatment of Triple-Negative Breast Cancer. Georg Thieme Verlag KG.
Chicago Style (17th ed.) CitationWei Zhang, Hong Liu, Wei-Liang Zhuang, Yuan Li, Li-Ping Xie, and You-Jia Hu. A Potential Antibody-Drug Conjugate Targeting Human LIV1 for the Treatment of Triple-Negative Breast Cancer. Georg Thieme Verlag KG, 2023.
MLA (9th ed.) CitationWei Zhang, et al. A Potential Antibody-Drug Conjugate Targeting Human LIV1 for the Treatment of Triple-Negative Breast Cancer. Georg Thieme Verlag KG, 2023.
Warning: These citations may not always be 100% accurate.